Knockout of Ca
Animals
Calcium Channels, L-Type
/ deficiency
Cyclic Nucleotide Phosphodiesterases, Type 6
/ deficiency
Disease Models, Animal
Immunohistochemistry
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Mutant Strains
Retinal Cone Photoreceptor Cells
/ metabolism
Retinal Rod Photoreceptor Cells
/ metabolism
Retinitis Pigmentosa
/ genetics
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 07 2021
26 07 2021
Historique:
received:
06
05
2021
accepted:
09
07
2021
entrez:
27
7
2021
pubmed:
28
7
2021
medline:
4
11
2021
Statut:
epublish
Résumé
Retinitis Pigmentosa is a genetically heterogeneous, degenerative retinal disorder characterized by gradual dysfunction and death of photoreceptors, first rods and later cones, and progressive blindness. Studies suggested that application of L-type calcium channel blockers rescues photoreceptors in paradigms related to Ca
Identifiants
pubmed: 34312410
doi: 10.1038/s41598-021-94304-3
pii: 10.1038/s41598-021-94304-3
pmc: PMC8313562
doi:
Substances chimiques
Cacna1d protein, mouse
0
Calcium Channels, L-Type
0
Cyclic Nucleotide Phosphodiesterases, Type 6
EC 3.1.4.35
Pde6b protein, mouse
EC 3.1.4.35
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15146Informations de copyright
© 2021. The Author(s).
Références
Vis Neurosci. 2005 Sep-Oct;22(5):561-8
pubmed: 16332266
Prog Retin Eye Res. 2015 Mar;45:58-110
pubmed: 25307992
Cell Signal. 2014 May;26(5):968-78
pubmed: 24407175
FASEB J. 2006 Jan;20(1):178-80
pubmed: 16282372
Cell Signal. 2015 Nov;27(11):2231-40
pubmed: 26235199
Metab Brain Dis. 2002 Sep;17(3):183-97
pubmed: 12322788
Exp Eye Res. 1997 Jul;65(1):45-50
pubmed: 9237863
Invest Ophthalmol Vis Sci. 1995 Feb;36(2):263-75
pubmed: 7843898
Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1912-5
pubmed: 12036998
Eur J Neurosci. 2013 Jun;37(11):1853-62
pubmed: 23551187
PLoS One. 2014 Jan 21;9(1):e86769
pubmed: 24466230
Nat Commun. 2019 Apr 18;10(1):1817
pubmed: 31000720
Adv Exp Med Biol. 2002;514:439-50
pubmed: 12596937
Biochem Biophys Res Commun. 2004 Jan 23;313(4):1015-22
pubmed: 14706644
Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2697-701
pubmed: 10937585
FASEB J. 2001 Apr;15(6):970-7
pubmed: 11292657
Sci Rep. 2021 Feb 1;11(1):2732
pubmed: 33526839
Eur J Neurosci. 2009 Apr;29(8):1533-42
pubmed: 19385989
Neurosci Lett. 2002 Sep 6;329(3):297-300
pubmed: 12183035
Mol Vis. 2001 Feb 25;7:42-7
pubmed: 11239245
Invest Ophthalmol Vis Sci. 1994 Dec;35(13):4182-91
pubmed: 8002239
Prog Retin Eye Res. 2003 Sep;22(5):607-55
pubmed: 12892644
Life Sci. 1997;61(21):2083-90
pubmed: 9395249
Hum Mol Genet. 2005 Oct 15;14(20):3035-46
pubmed: 16155113
Neuroscience. 2008 Aug 26;155(3):698-713
pubmed: 18639614
J Comp Neurol. 2007 Jan 10;500(2):222-38
pubmed: 17111372
Vision Res. 2002 Feb;42(4):517-25
pubmed: 11853768
Channels (Austin). 2018 Jan 1;12(1):17-33
pubmed: 29179637
Exp Eye Res. 2002 Oct;75(4):415-20
pubmed: 12387789
PLoS One. 2014 Nov 13;9(11):e112142
pubmed: 25392995
Mol Vis. 2007 Mar 27;13:443-56
pubmed: 17417605
J Comp Neurol. 1974 Jul 1;156(1):95-106
pubmed: 4836657
Nat Med. 1999 Oct;5(10):1183-7
pubmed: 10502823
J Ocul Pharmacol Ther. 2009 Dec;25(6):545-50
pubmed: 20028262
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2724-34
pubmed: 10509671
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11020-5
pubmed: 10995468
Biochem Biophys Res Commun. 2003 Jul 11;306(4):826-31
pubmed: 12821116
Int J Neuropsychopharmacol. 2010 May;13(4):499-513
pubmed: 19664321
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):919-26
pubmed: 11923229
Adv Exp Med Biol. 2019;1185:245-249
pubmed: 31884619
Int J Mol Sci. 2018 Mar 07;19(3):
pubmed: 29518895
Ophthalmologica. 2011;225(2):120-6
pubmed: 20948238
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17366-71
pubmed: 17088543
Curr Eye Res. 2009 Mar;34(3):231-7
pubmed: 19274531
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Invest Ophthalmol Vis Sci. 1978 Jun;17(6):489-98
pubmed: 659071
Vision Res. 2012 Dec 15;75:53-9
pubmed: 22892111
Mol Vis. 2007 May 23;13:764-71
pubmed: 17563731
Prog Retin Eye Res. 2015 Sep;48:62-81
pubmed: 26113212
Cell. 2000 Jul 7;102(1):89-97
pubmed: 10929716
Invest Ophthalmol Vis Sci. 1988 Sep;29(9):1363-71
pubmed: 3417421
BMC Ophthalmol. 2015 Apr 30;15:44
pubmed: 25925748
Nature. 1990 Oct 18;347(6294):677-80
pubmed: 1977087
FASEB J. 2020 Mar;34(3):4055-4071
pubmed: 31930599
J Neurosci. 1998 Nov 1;18(21):8936-46
pubmed: 9786999
Front Cell Neurosci. 2018 Sep 10;12:298
pubmed: 30250425
PLoS One. 2012;7(11):e50726
pubmed: 23209820
J Gen Physiol. 1996 May;107(5):621-30
pubmed: 8740375
Channels (Austin). 2015;9(5):298-306
pubmed: 26274509
Exp Eye Res. 2010 Nov;91(5):630-9
pubmed: 20696156
Front Mol Neurosci. 2017 Dec 05;10:394
pubmed: 29259539
Bioessays. 2001 Jul;23(7):605-18
pubmed: 11462214
PLoS One. 2016 Jun 07;11(6):e0156974
pubmed: 27270916
Channels (Austin). 2013 Nov-Dec;7(6):514-23
pubmed: 24064553
Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):12
pubmed: 32503050
PLoS One. 2014 Aug 25;9(8):e106047
pubmed: 25153888
Invest Ophthalmol Vis Sci. 2015 May;56(5):3132-9
pubmed: 26024096
JCI Insight. 2019 Mar 19;5:
pubmed: 30888334
Front Cell Neurosci. 2015 Nov 09;9:444
pubmed: 26617491